MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
© 1990 Nature Publishing Group
© 1990 Nature Publishing Group
© 1990 Nature Publishing Group
© 1990 Nature Publishing Group
Suggest Documents
Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development.
HinfI polymorphism within the 3' untranslated region of the candidate Wilms tumour gene.
Akt pathway.
Molecular genetics. A gene for Wilms tumour?
Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.
Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours.
Aniridia-Wilms' tumour syndrome.
Antenatally diagnosed wilms' tumour.
Erythrocytosis and Wilms' tumour.
Wilms' Tumour gene 1 (WT1) as an immunotherapeutic target.
Letter: Survival in Wilms' tumour.
Adult Wilms' Tumour.
Role for the Wilms tumor gene in genital development?
The QM gene is X-linked and therefore not involved in suppression of tumorigenesis in Wilms' tumor.
Wilms' tumour in New Zealand 1960-1986.
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene.
Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour.
Wilms' tumour: reconciling genetics and biology.
Musculoskeletal deformities following treatment of Wilms' tumour.
Treatment of Wilms' tumour. Current recommendations.
Novel mutation in Wilms' tumour 1 gene associated with steroid-resistant nephrotic syndrome.
How curable is relapsed Wilms' tumour? The United Kingdom Children's Cancer Study Group.
TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.
WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
The candidate Wilms' tumour gene is involved in genitourinary development.
Wilms' tumour is an embryonic kidney tumour thought to arise through aberrant mesenchymal stem cell differentiation and to result from loss of functio...
714KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development.
HinfI polymorphism within the 3' untranslated region of the candidate Wilms tumour gene.
Akt pathway.
Molecular genetics. A gene for Wilms tumour?
Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.
Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours.
Aniridia-Wilms' tumour syndrome.
Antenatally diagnosed wilms' tumour.
Erythrocytosis and Wilms' tumour.
Wilms' Tumour gene 1 (WT1) as an immunotherapeutic target.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms